" BioVaxys (CSE:BIOV) reports progress on a universal SARS vaccine

BioVaxys (BIOV) and Ohio State University report progress on a universal vaccine to treat a range of SARS viruses.
The Market Herald Video

" BioVaxys (CSE:BIOV) expands cancer vaccine platform

BioVaxys Technology Corp. (BIOV) has expanded its cancer vaccine platform with BVX-0922, its autologous haptenized tumor vaccine for colorectal cancer.

" Top 5 Stories of the Week: Odd Burger (TSXV:ODD), X-Terra Resources (TSXV:XTT), BioVaxys (CSE:BIOV), Monarch Mining (TSX:GBAR), Trillion Energy (CSE:TCF)

The week in Canadian markets is ending with a sense of trepidation for stocks in the near term.